Company / Net Income
Caris Life Sciences, Inc. Net Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$68.1M
FY2025
5-year range
-$341.4M / -$68.1M
FY2023-FY2025
Trend
+75.8%
vs FY2024
Sector context
#120 of 163
Health Care
What the data says
At -$68M, Caris Life Sciences, Inc.'s net income ranks #120 of 163 in the Health Care sector. Improved from -$341M to -$68M over the past 2 years.
Based on SEC 10-K filings.
-$68M in FY2025.
Improved from -$341M to -$68M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 163 in Health CareTop 74% of 163This company -$68.1M Sector average $467.8M
▼
-114.6% below sector average
Key checks
Key Insights
- In FY2025, net income increased 75.8% year-over-year.
- Ranks #120 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$68.1M | +75.8% |
| FY2024 | -$281.9M | +17.4% |
| FY2023 | -$341.4M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026